Meeting 5: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action

The Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session for the public on Wednesday, September 11, 2019. This open session will include a panel of industry speakers who are currently developing therapeutic and curative products for sickle cell disease. The purpose of this session is to have manufacturers share their perspectives with the committee about the range of products in development, the regulatory process, and considerations for ensuring widespread access to pipeline products. More information about this session, including agenda and speakers will be forthcoming.